Poly‐ IC Alleviates Nitroglycerin‐Induced Migraine by Inhibiting Neuroinflammation via TLR3 / TRIF Signaling Pathway
CNS Neuroscience & Therapeutics · 2025
DOI: 10.1111/cns.70444 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Ye Hong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, West China Hospital of Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Toll-Like Receptor 3, Poly I-C, Signal Transduction, Migraine Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation funded project.
Abstract (Originalsprache)
Aims
Toll‐like receptors (TLRs) play critical roles in pain modulation and immune responses. Polyinosinic‐polycytidylic acid (Poly‐IC), a TLR3‐specific ligand, has shown promise in exerting neuroprotective effects, as it mitigates inflammation in several diseases. Considering that sterile neurogenic inflammation is involved in the pathogenesis of migraine, we explored the impact of Poly‐IC on episodic migraine treatment and the potential mechanisms involved.
Methods
Episodic migraine was induced in male rats via a single intraperitoneal injection of nitroglycerin. Poly‐IC (with or without a TLR3 inhibitor) treatment was performed before migraine induction. Pain was assessed according to the mechanical sensitivity threshold, head‐directed grooming, and the Rat Grimace Scale. The expression of TLR3 and its downstream molecule TRIF was subsequently examined, after which calcitonin gene‐related peptide (CGRP), c‐fos, and proinflammatory cytokine expression was assessed. Moreover, TRIF expression in primary cultured neurons was knocked down by shRNA in vitro to further explore the mechanisms by which Poly‐IC mediates migraine‐like inflammation.
Results
Poly‐IC treatment significantly upregulated TLR3/TRIF expression, reduced the production of CGRP, c‐fos, and inflammatory cytokines, and alleviated allodynia in an animal model of migraine. Moreover, TRIF knockdown blunted the anti‐inflammatory effects of Poly‐IC treatment in primary cultured neurons.
Conclusions
Poly‐IC exerts therapeutic effects against neurogenic inflammation via the TLR3/TRIF signaling pathway in an episodic migraine model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, West China Hospital of Sichuan University, Chengdu, China.
- Department of Neurology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
ORCID-Profile: Jinghuan Fang, Li He
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation funded project
Zitieren
APA
Hong, Y., Ma, M., Li, C., Zhang, Y., Li, Y., Chen, N., Fang, J., & He, L. (2025). Poly‐ IC Alleviates Nitroglycerin‐Induced Migraine by Inhibiting Neuroinflammation via TLR3 / TRIF Signaling Pathway. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70444
Vancouver
Hong Y, Ma M, Li C, Zhang Y, Li Y, Chen N, et al. Poly‐ IC Alleviates Nitroglycerin‐Induced Migraine by Inhibiting Neuroinflammation via TLR3 / TRIF Signaling Pathway. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70444
BibTeX
@article{Hong2025,
author = {Hong, Ye and Ma, Mengmeng and Li, Changling and Zhang, Yang and Li, Yanbo and Chen, Ning and Fang, Jinghuan and He, Li},
title = {Poly‐ IC Alleviates Nitroglycerin‐Induced Migraine by Inhibiting Neuroinflammation via TLR3 / TRIF Signaling Pathway},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
doi = {10.1111/cns.70444}
}
EUVIMED